Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization

International Journal of Pharmaceutics

Volumn 385, Issue 1-2, 2010, Pages 53-65

  Mallipeddi, Rama ^a   Saripella, Kalyan K ^a   Neau, Steven H ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Central composite design; Ethylcellulose; Extrusion spheronization; Optimization; Polyethylene oxide; Response surface method

Indexed keywords

CAFFEINE; DILUENT; ETHYL CELLULOSE; EXCIPIENT; MACROGOL; MICROCRYSTALLINE CELLULOSE;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL DESIGN; FACTORIAL DESIGN; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SPHERONIZATION; STATISTICAL ANALYSIS; WATER CONTENT;

CAFFEINE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EXCIPIENTS; FEASIBILITY STUDIES; KINETICS; MODELS, STATISTICAL; MOLECULAR WEIGHT; PARTICLE SIZE; POLYETHYLENE GLYCOLS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 72149130531     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.028     Document Type: Article

References (39)

1. Agrawal A.M., Howard M.A., and Neau S.H. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables. Pharm. Dev. Technol. 9 (2004) 197-217
2. Apicella A., Cappello B., Del Nobile M.A., La Rotonda M.I., Mensitieri G., and Nicolais L. Poly (ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. Biomaterials 14 (1993) 83-90
3. Barrau J.P., Bataille B., and Jacob M. The influence of spheronizer load in extrusion-spheronization. Pharm. Tech. Int. Biophys. 5 (1993) 66-70
4. Basit A.W., Newton M., and Lacey L.F. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Technol. 4 (1999) 499-505
5. Brandl M., Magill A., Rudraraju V., and Gordon M.S. Approaches for improving the stability of ketorolac in powder blends. J. Pharm. Sci. 84 (1995) 1151-1153
6. Carstensen J.T., Osadca M., and Rubin S.H. Degradation mechanisms for water-soluble drugs in solid dosage forms. J. Pharm. Sci. 58 (1969) 549-553
7. Charoenthai N., Kleinebudde P., and Puttipipatkhachorn S. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization. J. Pharm. Sci. 96 (2007) 2469-2484
8. Dabbagh M.A., Ford J.L., Rubenstein M.H., and Hogan J.E. Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices containing ethylcellulose. Int. J. Pharm. 140 (1996) 85-95
9. Derringer G.C., and Suich R. Simultaneous optimization of several response variables. J. Qual. Technol. 12 (1980) 214-219
10. Dukic-Ott A., Thommes M., Remon J.P., Kleinebudde P., and Vervaet C. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur. J. Pharm. Sci. 71 (2009) 38-46
11. George R.C., Barbuch R.J., Huber E.W., and Regg B.T. Investigation into the yellowing on aging Sabril tablet cores. Drug Dev. Ind. Pharm. 20 (1994) 3023-3032
12. Hileman G.A., Goskonda S.R., Spalitto A.J., and Upadrashta S.M. A factorial approach to high dose product development by an extrusion/spheronization process. Drug Dev. Ind. Pharm. 19 (1993) 483-491
13. Hileman G.A., Upadrashta S.M., and Neau S.H. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets. Pharm. Dev. Technol. 2 (1997) 43-52
14. Hong S.I., and Oh S.Y. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol. Int. J. Pharm. 5 (2008) 121-129
15. Howard, M.A., 2004. The application of polyethylene oxide (PolyOx(R)) and methoxypolyethylene glycol (Carbowax Sentry(R)) in the production of extruded-spheronized beads with a high drug load, Ph.D. dissertation, University of Missouri - Kansas City, Kansas City, Missouri, United States.
16. Howard M.A., Neau S.H., and Sack M.J. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int. J. Pharm. 307 (2006) 66-76
17. Jover I., Podczeck F., and Newton M. Evaluation, by a statistically designed experiment, of an experimental grade of microcrystalline cellulose, Avicel 955, as a technology to aid the production of pellets with high drug loading. J. Pharm. Sci. 85 (1996) 700-705
18. Katikaneni P.R., Upadrashta S.M., Neau S.H., and Mitra A.K. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int. J. Pharm. 123 (1995) 119-125
19. Katikaneni P.R., Upadrashta S.M., Rowlings C.E., Neau S.H., and Hileman G.A. Consolidation of ethylcellulose: effect of particle size, press speed and lubricants. Int. J. Pharm. 117 (1995) 13-21
20. Kim C.J. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. Drug Dev. Ind. Pharm. 24 (1998) 645-651
21. Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization. Pharm. Res. 14 (1997) 804-809
22. Kleinebudde P., Schroder M., Schultz P., Muller B.W., Waaler T., and Nymo L. Importance of the fraction of microcrystalline cellulose and spheronization on the properties of extruded pellets made from binary mixtures. Pharm. Dev. Technol. 4 (1999) 397-404
23. Kojima H., Yoshihara K., Sawada T., Kondo H., and Sako K. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Eur. J. Pharm. Biopharm. 70 (2008) 556-562
24. Krause J., Thommes M., and Breitkreutz J. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion. Eur. J. Pharm. Biopharm. 71 (2009) 138-144
25. Ku C.C., Joshi Y.M., Bergum J.S., and Jain N.B. Bead manufacture by extrusion-spheronization- a statistical design for process optimization. Drug Dev. Ind. Pharm. 19 (1993) 1505-1519
26. Maggi L., Bruni R., and Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int. J. Pharm. 195 (2000) 229-238
27. Maggi L., Segale L., Torre M.L., Ochoa M.E., and Conte U. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials 23 (2002) 1113-1119
28. Montgomery D.C. Design and Analysis of Experiments. fifth ed. (2001), Wiley & Sons, New York
29. Newton J.M., Pinto M.R., and Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-glycerides by extrusion/spheronization. Eur. J. Pharm. Sci. 30 (2007) 333-342
30. Patel N.K., Patel I.J., Cutie A.J., Wadke D.A., Monkhouse D.C., and Reier G.E. The effect of selected direct compression excipients on the stability of aspirin A as a model hydrolyzable drug. Drug Dev. Ind. Pharm. 14 (1988) 77-98
31. Pinto J.F., Wunder K.F., and Okoloekwe A. Evaluation of the potential use of poly (ethylene oxide) as tablet- and extrudate-forming material. AAPS J. 6 (2004) 17-26
32. Prodduturi S., Urman K.L., Otaigbe J.U., and Repka M.A. Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech. 8 (2007) E1-E10
33. Repka M.A., and McGinity J.W. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int. J. Pharm. 202 (2000) 63-70
34. Signoretti E.C., Dell'Utri A., DeSalvo A., and Donini L. Compatibility study between clenbuterol and tablet excipients using differential scanning calorimetry. Drug Dev. Ind. Pharm. 12 (1986) 603-620
35. Tho I., Sande S.A., and Kleinebudde P. Pectinic acid, a novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur. J. Pharm. Biopharm. 54 (2002) 95-99
36. Thommes M., and Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur. J. Pharm. Biopharm. 63 (2006) 68-75
37. Torres A.I., and Camacho M.A. Solid state interactions of two new antineoplastic drugs (mitonafide and amonafide) and common tablet excipients in preformulation studies. Eur. J. Pharm. Biopharm. 40 (1994) 41-43
38. Vervaet C., Baert L., and Remon J.P. Extrusion-spheronization: a literature review. Int. J. Pharm. 116 (1995) 131-146
39. Yang L., Venkatesh G., and Fassihi R. Characterization of compressibility and compactibility of poly(ethylene oxide) polymers for modified release application by compaction simulator. J. Pharm. Sci. 85 (1996) 1085-1090